TrialThe journal of headache and pain2021

Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine.

C Tassorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.